Todd M. Cooper, Janet Franklin, Robert B. Gerbing, Todd A. Alonzo, Craig Hurwitz, Susana C. Raimondi, Betsy Hirsch, Franklin O. Smith, Prasad Mathew, Robert J. Arceci, James Feusner, Robert Iannone, Robert S. Lavey, Soheil Meshinchi and Alan Gamis AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia Cancer 118
Article first published online: 15 JUL 2011 | DOI: 10.1002/cncr.26190
Children's Oncology Group Study AAML03P1 determined the safety and efficacy of gemtuzumab in combination with intensive chemotherapy. The survival rates compare favorably with the recently published results of pediatric acute myeloid leukemia clinical trials worldwide.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field